Parkwalk News

16 October 2017

Paragraf – Parkwalk and UCEF V investment

By |October 16th, 2017|

We are delighted to announce that the University of Cambridge Enterprise Fund V and the Parkwalk Opportunities Fund have invested in £2.64m seed financing round in Paragraf, a spin-out from the University of Cambridge.

Paragraf is aiming to deliver the speculated capabilities of graphene and other two-dimensional materials to the real world.

Building on fundamental science […]

MedaPhor – Parkwalk investment

By |October 13th, 2017|

We are delighted to announce that the Parkwalk Opportunities Fund has  participated in the recent financing round of Medaphor Group plc, the Cardiff University Spin-out and global provider of advanced ultrasound training simulators for medical professionals.

13 September 2017

PsyOmics – follow-on investment

By |September 13th, 2017|

We are delighted to announce that the University of Cambridge Enterprise Fund V and the Parkwalk Opportunities Fund have invested in a follow-on financing round in PsyOmics, a spin-out from the Department of Chemical Engineering and Biotechnology.

The company aims to utilise blood-based diagnostics to increase the speed of diagnosis and to reduce misdiagnosis for […]

Oxford Quantum Circuits – Parkwalk investment

By |September 8th, 2017|

We are delighted to announce that the Parkwalk Opportunities Fund has completed an investment in Oxford Quantum Circuits Limited. The company was founded by Professor Peter Leek, who is based at the Clarendon Laboratory Oxford, and is aiming to build a quantum computer based upon a superconducting circuit approach to forming qubits. The intention […]

Ionix – Parkwalk closes follow-on investment

By |September 5th, 2017|

We are pleased to announce that the Parkwalk Opportunities EIS Fund has participated in a follow-on financing round into Ionix Advanced Technologies, a Leeds University Spin-out that has developed extreme temperature piezo technology for use in the protection of high value industrial assets. Parkwalk invested alongside existing investor IP Group plc.

The market for piezo technologies […]

Inkpath – University of Oxford Innovation Fund III investment

By |September 4th, 2017|

We are delighted to announce that the University of Oxford Enterprise Fund III has completed its penultimate investment in Inkpath, a data-driven software platform aiming to be the “Fitbit for your career.”

Inkpath is the first comprehensive, data-driven software platform to help its users plan and track their career development in a smart format, with user […]

Mind Foundry – Parkwalk closes follow-on investment

By |September 4th, 2017|

We are delighted to announce that the Parkwalk Opportunities Fund has completed a follow-on investment in Mind Foundry, an Oxford Spin-out company with technology that uses advanced machine learning algorithms to help organisations solve problems by unlocking insights hidden deep within their big data.

Mind Foundry is the result of collaboration between two prominent members […]

9 August 2017

Inductosense – University of Bristol Enterprise Fund II investment

By |August 9th, 2017|

We are delighted to announce that the University of Bristol Enterprise Fund II, managed by Parkwalk, has invested in Inductosense.

Inductosense specialises in the development of compact, wireless sensors for fast, repeatable detection of cracks, corrosion or defects in structures or products.

The company’s aim is to become the leading provider of permanently installed non-destructive testing (NDT) […]

17 July 2017

Parkwalk H1 2017 update

By |July 17th, 2017|

It has been a busy first half of the year at Parkwalk. Our proprietary access to deal-flow has enabled us to deploy £46.5m in the last 12 months. Deal-flow has been enhanced by our tie-up with IP Group plc, who recently raised a further £200m to co-invest in the university spin-out sector.

The combined group […]

YASA Motors – Parkwalk closes follow-on investment

By |July 12th, 2017|

We are delighted to announce that the Parkwalk Opportunities Fund has led a funding round in YASA Motors, a spin-out from the University of Oxford. The company aims to commercialise its patented technology in electric motors and generators across a range of product areas.

YASA Motors (YASA) was incorporated in 2009 to commercialise the unique motor topology developed […]

Ilika plc – Financial statements for year ended 30 April 2017

By |July 11th, 2017|

11 Jul 2017

Ilika (AIM: IKA), the accelerated materials innovation company, announces its audited full-year results for the year ended 30 April 2017.
Operational highlights:
·     Launch of StereaxTM P180, the extended temperature range solid-state battery
·     Collaboration with a bioelectronics company to develop Stereax for miniature medical implants
·    Collaboration with Sharp to integrate Stereax solid-state batteries with Sharp’s photovoltaic technology
·     Grant of […]

Xeros Technology Group plc – Signs 10 year contract with leading European tannery

By |July 11th, 2017|

Xeros Technology Group plc has signed a 10 year contract with Wollsdorf Leder Schmidt & Co. Ges.m.b.h (‘Wollsdorf’) to convert its re-tanning operations in Austria to use Xeros’ patented polymer technology. This contract follows the previously announced heads of terms in January 2017.

Wollsdorf, which was awarded Global Tannery of the Year in 2014 by […]

Cycle.land – University of Oxford Innovation Fund III investment

By |July 11th, 2017|

We are delighted to announce that the University of Oxford Enterprise Fund III has completed an investment in Cycle.land Limited, a company helping the move toward sustainable urban transport by creating a global peer-to-peer social marketplace on which to share bicycles. Cycle.land was supported by the Oxford University Innovation Incubator.

Bicycles, like cars, are not in […]

Creavo Medical Technologies – Parkwalk closes investment

By |July 3rd, 2017|

We are pleased to announce that the Parkwalk Opportunities Fund has made an investment in Creavo Medical Technologies, a University of Leeds Spin-out company, as part of a £13.4 million fundraising.

The round was oversubscribed, exceeded Creavo’s funding target and was strongly supported by existing shareholders including IP Group plc, the University of Leeds, and new, private and […]

30 May 2017

Zegami – Parkwalk closes follow on investment

By |May 30th, 2017|

We are pleased to announce that the Parkwalk Opportunities Fund and the University of Oxford Innovation Fund III have made an investment in Zegami, an Oxford University Spin-out company, as part of a Series A investment round of equity funding.

The technology provides data discovery and analytics tools to manage and sort collections of images and […]

Horizon Discovery – Parkwalk UCEF I exit

By |May 19th, 2017|

We are delighted to have generated a 2.36x return (3.37x inclusive of initial tax reliefs) for our investors on the sale of the University of Cambridge Enterprise Fund I holding in Horizon Discovery plc. The investment was held for 3.9 years and the exit was generated through a single block trade.
We would like to thank […]

Predictimmune – Parkwalk closes investment

By |May 16th, 2017|

We are delighted to announce that the Parkwalk Opportunities Fund and the University of Cambridge Enterprise Fund IV have completed an investment in Predictimmune Limited, a spinout company from the University of Cambridge.
Predictimmune is developing prognostic tests for immune-mediated conditions to aid their management and improve patient outcomes. Their first offering, PredictImmune-CD, will be […]

Brainomix joins forces with Boehringer Ingelheim to help save stroke victims

By |May 9th, 2017|

Oxford – An ambitious collaboration between Brainomix, an emerging British business, and Boehringer Ingelheim, one of the world’s largest drug companies, is poised to expedite and improve treatment of stroke, the second biggest killer disease in Europe.

The Brainomix team has pioneered the rapid digital analysis of scans of patients admitted to hospital with stroke. […]

8 April 2017

Azul Optics – University of Bristol Enterprise Fund I investment

By |April 8th, 2017|

We are delighted to announce that the University of Bristol Enterprise Fund I, managed by Parkwalk, has invested in Azul Optics.

Azul Optics is developing a device that can rapidly assess macular pigment density. The device will be affordable, fast, easy-to-use and compact, making it easy to integrate macular pigment density screening into regular eye exams. […]

Microsaic Systems – signs amended agreement with Global Partner

By |April 7th, 2017|

Microsaic Systems plc (AIM: MSYS), the developer of chip-based mass spectrometry instruments, announces that it has signed an amendment to its Research Collaboration Agreement with a long standing global partner. The amended agreement is a precursor to future collaboration in the area of bio-processing.

Interim Chairman, Eric Yeatman commented:

“We are delighted to sign this […]